HK Stock MarketDetailed Quotes

ZHAOKE OPHTH-B (06622)

Watchlist
  • 2.465
  • -0.045-1.79%
15min DelayNot Open Sep 23 15:38 CST
1.35BMarket Cap-5.47P/E (TTM)

ZHAOKE OPHTH-B (06622) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2026/H1
Stock NameRevenueRatio
销售眼科药物15.37M81.63%
Sale of other drugs1.54M8.15%
独家分销权收入998K5.30%
销售眼科产品725K3.85%
CMO服务收入201K1.07%

By Product

Currency:CNY
2026/H1
Stock NameRevenueRatio
销售眼科药物15.37M81.63%
Sale of other drugs1.54M8.15%
独家分销权收入998K5.30%
销售眼科产品725K3.85%
CMO服务收入201K1.07%

By Country/Region

Currency:CNY
2026/H1
Stock NameRevenueRatio
China Mainland17.21M91.41%
South Korea745K3.96%
Other454K2.41%
中国香港(所在地)418K2.22%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More